[Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].
Furukawa
Hisashi
H
Third Department of Internal Medicine, Kyorin University School of Medicine.
Ishida
Hitoshi
H
D000284:Administration, Oral; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D015430:Weight Gain / Q000187:drug effects
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds